BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29404169)

  • 21. Alteration of H2 receptor sensitivity in duodenal ulcer patients after maintenance treatment with an H2 receptor antagonist.
    Jones DB; Howden CW; Burget DW; Silletti C; Hunt RH
    Gut; 1988 Jul; 29(7):890-3. PubMed ID: 2969357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stress ulcer prophylaxis in patients on ventilator.
    Darlong V; Jayalakhsmi TS; Kaul HL; Tandon R
    Trop Gastroenterol; 2003; 24(3):124-8. PubMed ID: 14978984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One-week antibiotics versus maintenance acid suppression therapy for Helicobacter pylori-associated peptic ulcer bleeding.
    Sung JJ; Leung WK; Suen R; Leung VK; Chan FK; Ling TK; Lau JY; Lee YT; Ng EK; Cheng AF; Chung SC
    Dig Dis Sci; 1997 Dec; 42(12):2524-8. PubMed ID: 9440631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
    Bardhan KD; Naesdal J; Bianchi Porro G; Petrillo M; Lazzaroni M; Hinchliffe RF; Thompson M; Morris P; Daly MJ; Carroll NJ
    Gut; 1991 Apr; 32(4):435-8. PubMed ID: 1673953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serum concentration of prolactin, gastrin and glycocholic acid in patient with peptic ulcer treated with ranitidine].
    Przybyłowski J; Kowalski D; Widłak H; Kowalska K; Maślany P
    Pol Tyg Lek; 1995; 50(1-35):794-6. PubMed ID: 11785198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatal anaphylaxis of ranitidine injection : have we not learnt the lesson yet?
    Chuah YY; Lee YY; Lin LF; Kuo CJ
    Acta Gastroenterol Belg; 2019; 82(3):449-450. PubMed ID: 31566338
    [No Abstract]   [Full Text] [Related]  

  • 27. Does H2 receptor antagonist-resistant ulcer exist?--A review based on bioavailability in man.
    Kawai K
    Gastroenterol Jpn; 1992 Jun; 27(3):418-23. PubMed ID: 1624085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The treatment of "cimetidine resistant" peptic ulcers by ranitidine hydrochloride: a new histamine H2-receptor antagonist.
    Mohammed R; Mitchell KG; Mackay C
    Curr Med Res Opin; 1981; 7(8):523-5. PubMed ID: 6118237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intragastric pH monitoring in acute upper gastrointestinal bleeding and the effect of intravenous cimetidine and ranitidine.
    Reynolds JR; Walt RP; Clark AG; Hardcastle JD; Langman MJ
    Aliment Pharmacol Ther; 1987 Feb; 1(1):23-30. PubMed ID: 2979209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Newly developed H2-receptor antagonists in the treatment of peptic ulcer disease].
    Simon B; Müller P; Dammann HG
    Wien Med Wochenschr; 1982 May; 132(10):223-8. PubMed ID: 6126962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ranitidine, a new histamine H2 receptor antagonist. First experimental and clinical data].
    Simon B; Dammann HG; Müller P; Kather H
    Minerva Med; 1981 Oct; 72(40):2657-61. PubMed ID: 6117040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. A randomized controlled trial.
    Prod'hom G; Leuenberger P; Koerfer J; Blum A; Chiolero R; Schaller MD; Perret C; Spinnler O; Blondel J; Siegrist H; Saghafi L; Blanc D; Francioli P
    Ann Intern Med; 1994 Apr; 120(8):653-62. PubMed ID: 8135449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.
    Brogden RN; Carmine AA; Heel RC; Speight TM; Avery GS
    Drugs; 1982 Oct; 24(4):267-303. PubMed ID: 6128216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Henoch-Schonlein purpura associated with ranitidine.
    Prajapati C; Casson IF
    Int J Clin Pract; 1997 Jun; 51(4):251. PubMed ID: 9287270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nizatidine versus ranitidine in the treatment of peptic ulcer disease: report on the Dutch investigation as part of a European multicentre trial.
    Kuipers EJ; Hazenberg HJ; Quik RF; Hazenberg BP; de Zwart PA
    Neth J Med; 1990 Aug; 37(1-2):58-62. PubMed ID: 1977089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamics of gastric acid inhibition by ranitidine in duodenal ulcer patients.
    Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
    Digestion; 1981; 22(3):119-25. PubMed ID: 6116636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stress associated gastric bleeding in newborn--role of ranitidine.
    Sarna MS; Saili A; Dutta AK; Sharma D
    Indian Pediatr; 1991 Nov; 28(11):1305-8. PubMed ID: 1808052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of intravenous pantoprazole with intravenous ranitidine in peptic ulcer bleeding.
    Demetrashvili ZM; Lashkhi IM; Ekaladze EN; Kamkamidze GK
    Georgian Med News; 2013 Oct; (223):7-11. PubMed ID: 24214585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients.
    Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
    Scand J Gastroenterol Suppl; 1981 Jun; 69():91-9. PubMed ID: 6119789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal therapy for stress gastritis.
    Maier RV; Mitchell D; Gentilello L
    Ann Surg; 1994 Sep; 220(3):353-60; discussion 360-3. PubMed ID: 8092901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.